Overview
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Status:
Unknown status
Unknown status
Trial end date:
2014-07-01
2014-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare combination atorvastatin/fenofibric acid 10/135mg with atorvastatin 20mg monotherapy in the mixed hyperlipidemia who were not at lipid goals with atorvastatin 10mg monotherapy.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sang Hak LeeTreatments:
Atorvastatin
Atorvastatin Calcium
Fenofibrate
Fenofibric acid
Criteria
Inclusion Criteria:- patients of the age of 20years or older
- patients who have been taking atorvastatin 10mg 1 tab per day for more than 8 weeks
before screening
- patients who meet the following criteria
1. Low density lipoproteins-cholesterol level < 130mg/dL
2. 150mg/dL < Triglyceride level < 500mg/dL
3. HDL-cholesterol level < 45mg/dL
- patients who consent for the consent before enrolling the study
Exclusion Criteria:
- Allergic to HMG-CoA reductase inhibitor and fibrates
- uncontrolled Hypertension
- unstable angina, myocardial infarction, transient ischemic attack
- uncontrolled diabetes
- thyroid disease
- myopathy, rhabdomyolysis history
- alcoholic
- chronic diarrhea, gastrointestinal disease
- malignant tumor
- patients who are pregnant
- lactating woman